Viewing Study NCT04622566


Ignite Creation Date: 2025-12-24 @ 4:38 PM
Ignite Modification Date: 2025-12-29 @ 7:22 PM
Study NCT ID: NCT04622566
Status: UNKNOWN
Last Update Posted: 2020-11-13
First Post: 2020-10-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma
Sponsor: Peking University Cancer Hospital & Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module